Lung Recruitment Manoeuvre in Morbidly Obese Patients Underdoing Laparoscopic Bariatric Surgery
Conventional Versus Ultrasound-guided Lung Recruitment Manoeuvre in Morbidly Obese Patients Underdoing Laparoscopic Bariatric Surgery: Prospective Randomized Clinical Study
1 other identifier
interventional
78
1 country
2
Brief Summary
Lung ultrasonography is an easy-to-use, portable, non-invasive, visual, and non-radiative technique that has been widely used in clinical monitoring and diagnosis. Many studies have demonstrated that pulmonary ultrasonography can evaluate the degree of aeration loss and diagnose atelectasis accurately by using a validated semiquantitative score in the perioperative period, and lung ultrasonic imaging can be conducive to confirming the effects of lung recruitment manoeuvres. This clinical trial suggested that the use of ultrasound-guided recruitment maneuver in morbidly obese patients scheduled for laparoscopic bariatric surgery can improve the lung aeration, decrease the incidence of basal lung atelectasis, decrease the incidence of intraoperative\& postoperative oxygen desaturation, and reduce the incidence of post operative pulmonary complications. The aim of this prospective randomized clinical study is to compare the conventional recruitment manoeuvre and ultrasound-guided recruitment manoeuvre in morbidly obese patients scheduled for laparoscopic bariatric surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2023
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 11, 2023
CompletedStudy Start
First participant enrolled
August 14, 2023
CompletedFirst Posted
Study publicly available on registry
August 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2024
CompletedDecember 3, 2024
November 1, 2024
1.2 years
August 11, 2023
November 30, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the change of Lung Ultrasound Score
Assessment of the changes in the lung ultrasound score
2 hours
Secondary Outcomes (2)
The incidence of atelectasis
2 hours
The incidence of intra-operative desaturation
3 hours
Study Arms (2)
Conventional group (group C)
EXPERIMENTALPatients will be shifted to 100% Oxygen then; the recruitment maneuver will be performed by manual inflation with a pressure of 30 cmH2O for 30 seconds.
Ultrasound-guided group (group US)
EXPERIMENTALPatients will be shifted to 100% Oxygen then; the recruitment maneuver will be performed under the direct real-time guidance of ultrasound if atelectasis (defined as LUS of ≥ 2 for any of the 12 regions) is present. This will be done by manual inflation with a pressure of 10 cmH2O for 10 seconds, increased 10 cmH2O every 10 seconds until no collapsed areas are visible on the ultrasound, the maximum airway pressure will be limited to 40 cmH2O. This could be repeated if needed.
Interventions
the recruitment maneuver will be performed by manual inflation with a pressure of 30 cmH2O for 30 seconds.
the recruitment maneuver will be performed under the direct real-time guidance of ultrasound if atelectasis (defined as LUS of ≥ 2 for any of the 12 regions) is present. This will be done by manual inflation with a pressure of 10 cmH2O for 10 seconds, increased 10 cmH2O every 10 seconds until no collapsed areas are visible on the ultrasound, the maximum airway pressure will be limited to 40 cmH2O. This could be repeated if needed.
Eligibility Criteria
You may qualify if:
- adult morbidly obese patients of BMI more than 40, scheduled for laparoscopic bariatric surgery
You may not qualify if:
- Patient refusal
- Patients with history of severe obstructive or restrictive pulmonary disease.
- Patients with severe obstructive sleep apnea (OSA).
- Presence of emphysematous lung bullae.
- Decompensated cardiac disease (NYHA class 3 or 4).
- Patients with uncontrolled hepatic or renal disorders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tanta Universitylead
Study Sites (2)
Tanta University
Tanta, Algharbia, 31511, Egypt
Tanta University hospitals
Tanta, 31511, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sameh Ismaiel, M.D
Assistant Professor of Anesthesia and Intensive Care, Tanta University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- * The participants will be kept blind through the use of ultrasound assessment in both groups. * Outcome assessors will be blinded as they will be anesthesia resident and nurse not participating in the study.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Anesthesia and Intensive Care
Study Record Dates
First Submitted
August 11, 2023
First Posted
August 21, 2023
Study Start
August 14, 2023
Primary Completion
November 1, 2024
Study Completion
November 1, 2024
Last Updated
December 3, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- within 6 months after publishing the study.
- Access Criteria
- Contact samehabdelkhalik1982@gmail.com
The IPD will be available with the principle investigator within 6 months after publishing the study.